SANUWAVE Health, Inc. Common Stock
SNWVSANUWAVE Health, Inc. is a medical device company focused on developing and commercializing regenerative injury management solutions. It specializes in non-invasive, low-energy pulsed electromagnetic field (PEMF) therapy devices designed to promote healing in various musculoskeletal, diabetic, and cardiovascular conditions. The company aims to improve patient outcomes through innovative treatment technologies.
Company News
Sanuwave Health (NASDAQ: SNWV) reported Q1 2026 revenues of $9.6 million, up 3.1% from $9.3 million in Q1 2025, marking the highest Q1 quarterly revenue in company history. However, gross margin declined to 77.3% from 79.0% due to wholesale pricing for resellers. The company swung to a $1.1 million operating loss from $0.6 million operating incom...
Sanuwave Health, Inc. (NASDAQ: SNWV) announced it will host a conference call on May 13, 2026 at 8:30 AM ET to present Q1 2026 financial results. The company reported preliminary Q1 2026 revenue of $9.6-$9.7 million, representing a 3-4% year-over-year increase.
Sanuwave Health reported Q1 2026 preliminary revenues of $9.6-$9.7 million, representing 3-4% growth over Q1 2025 and in line with guidance. The company attributed lower-than-midpoint results to deals sliding out of the quarter due to reimbursement changes in the wound care space affecting skin substitutes and allografts. CEO Morgan Frank express...
Sanuwave Health announced record Q4 2025 revenues of $13.4 million (up 29.7% YoY) and full year 2025 revenues of $44.1 million (up 35% YoY). The company achieved record quarterly and annual results driven by UltraMist system sales (255 units in Q4, 624 for full year) and consumables revenue growth. Gross margin improved to 77.1% for full year 202...
Sanuwave Health, a wound care products company, will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from January 12-15, 2026, offering meetings with company management.
Related Companies
